Therapeutics - SuperDuperDiscounts

Why Viking Therapeutics Stock Popped Nearly 4% Today

Personal Finance / August 28, 2025

Numerous companies in the healthcare sector are feverishly busy developing obesity drugs, as these products have taken the medical world by storm. One of the more prominent developers, clinical-stage biotech Viking Therapeutics (VKTX +0.04%), saw its share price rise by almost 4% on Thursday on the back of encouraging research about a certain property of […]

Why Viking Therapeutics Stock Popped Nearly 4% Today Read More »

Here’s Why Shares in Viking Therapeutics Crashed This Week

The phase 2 trial results for its key drug didn’t pan out quite as planned. Shares in Viking Therapeutics (VKTX 0.70%) crashed by 35.9% in the week to Friday morning. The decline comes in a week when the company released its top-line results from its phase 2 trial of its lead drug VK2735 (oral dosing)